10-KPeriod: FY1998

BRISTOL MYERS SQUIBB CO Annual Report, Year Ended Dec 31, 1998

Filed March 30, 1999For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company's (BMY) 1998 10-K filing indicates a company focused on the pharmaceutical and consumer medicines sectors. While the provided text is primarily a directory listing of the filing's components and SEC website navigation, it signifies the official reporting of the company's financial performance and operational details for the fiscal year ending December 30, 1998. Investors would typically look to the full 10-K document for detailed financial statements, management's discussion and analysis of financial condition and results of operations, risk factors, and segment information to assess the company's health and future prospects. Given the limited information, a deep dive into specific financial metrics is not possible. However, the filing date of March 29, 1999, suggests that the report would cover key developments and financial outcomes from the preceding year, which would have been crucial for investors evaluating BMY's position in the market, its product pipeline, and its overall strategic direction during that period.

Key Highlights

  • 1The filing represents Bristol-Myers Squibb Company's official 1998 Annual Report (10-K), submitted on March 29, 1999.
  • 2The period covered by the report is the fiscal year ending December 30, 1998.
  • 3The company operates within the pharmaceutical and consumer medicines industries.
  • 4The provided text is a directory listing of the filing's contents rather than the full financial report.
  • 5Investors would need to access the full 10-K document to find detailed financial statements and operational analysis.

Frequently Asked Questions

The primary purpose of this 10-K filing is to provide a comprehensive annual overview of Bristol-Myers Squibb Company's financial performance, business operations, and risk factors for the fiscal year ending December 30, 1998. It is a mandatory filing with the U.S. Securities and Exchange Commission (SEC) for publicly traded companies.

A full 10-K filing typically includes audited financial statements (balance sheets, income statements, cash flow statements), management's discussion and analysis of financial condition and results of operations (MD&A), details on the company's business segments, extensive risk factors, legal proceedings, and information about executive compensation. The provided text is a directory and does not contain these details.

This 10-K filing was made on March 29, 1999, and it covers the company's fiscal year ending on December 30, 1998.

The provided text is a directory listing of the filing's components. To access the actual financial data and analysis, you would need to locate and review the full 10-K document, likely through the SEC's EDGAR database or the company's investor relations website, using the ticker symbol BMY and the filing date.